{
    "clinical_study": {
        "@rank": "139692", 
        "brief_summary": {
            "textblock": "The lack of a precise diagnostic technique for cerebral vasospasm associated with TBI limits\n      the ability to detect and treat this phenomenon. Surveillance Transcranial Doppler\n      ultrasonography (TCD) is the main medical instrument that is utilized to monitor\n      radiographic vasospasm following TBI, yet has its drawbacks such as inaccuracy, highly\n      operator dependent and more.\n\n      HS-1000 device, an investigational vasospasm detection device, has the potential to safely\n      diagnose and assess vasospasm with minimal discomfort to patients, allowing a new modality\n      for vasospasm measurement tool.\n\n      We aim to evaluate the correlation between the collected and analyzed data from the HS-1000\n      device and the clinical findings from the TCD tests post-SAH patients."
        }, 
        "brief_title": "An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sub Arachnoid Hemorrhage", 
            "Vasospasm"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Subarachnoid Hemorrhage", 
                "Vasospasm, Intracranial"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  SAH patients with a TCD test\n\n          -  Male or Female in the age range of 18-85 years\n\n          -  Expected survival > 14 days\n\n        Exclusion Criteria:\n\n          -  Local infection in the ear.\n\n          -  Pregnant/lactating women\n\n          -  Known allergy or hypersensitivity to any of the test materials or contraindication to\n             test materials\n\n          -  Subjects currently enrolled in or less than 30 days post-participation in other\n             investigational device or drug study(s), or receiving other investigational agent(s)\n\n          -  Any condition that may jeopardize study participation (e.g., abnormal clinical or\n             laboratory finding) or interpretation of study results, or may impede the ability to\n             obtain informed consent (e.g.,  mental condition) Note: As the trial does not affect\n             the patient's management, there is no limitation regarding patient's medications,\n             previous or post study procedures, etc.\n\n        Enrolled patients treatment will not change due to their participation in the trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "SAH patients with an expected TCD test"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02093182", 
            "org_study_id": "HS-007", 
            "secondary_id": "0026-14-TLV"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 19, 2014", 
        "location": {
            "contact": {
                "email": "carmitbh@tasmc.health.gov.il", 
                "last_name": "Carmit Ben Harosh, RN,MA", 
                "phone": "972-3-6974397"
            }, 
            "facility": {
                "address": {
                    "city": "Tel Aviv", 
                    "country": "Israel", 
                    "zip": "64239"
                }, 
                "name": "Tel Aviv Sourasky Medical Center"
            }, 
            "investigator": {
                "last_name": "Shady Jahshan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Retrospective, Open-Label, Non-Randomized, Study Designed to Evaluate the Correlation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Vasospasm Patients After Sub Arachnoid Hemorrhage", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The main goal of the study is to check the feasibility of the HeadSense's non-invasive head monitor to check vasospasm in patients which over went SAH. In order to validate the accuracy of the HeadSense's device, a statistical comparison will be done between the acoustic values from the Headsense device and the TCD outcome.", 
            "measure": "Accuracy analysis", 
            "safety_issue": "No", 
            "time_frame": "within the first 30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02093182"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The HeadSense device is non-invasive and radiation free, therefore no major safety issues are expected.\nDuring the trial, the patient will be monitored to make sure that no danger or damage is caused by the device. Although there is a small chance of adverse events, potential safety issues include:\nPerforation of the ear drum, caused by inserting the device to the patient's ears\nAllergic reaction caused by skin contact with the device (the parts that are attached to the skin are taken from an off the shelf stethoscope, so this is very unlikely to happen)\nDamage to hearing, caused by the generated sound (the sound is 10Db in strength and is being generated for 10 seconds, so hearing damage is very unlikely to happen", 
            "measure": "Safety analysis", 
            "safety_issue": "Yes", 
            "time_frame": "within the first 48 hours"
        }, 
        "source": "HeadSense Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "HeadSense Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}